TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
GH

Guardant Health Inc

Healthcare · Diagnostics & Research

183.10$ +4.7% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Guardant Health Inc (GH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 335 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GH
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
143 155 168 177 191 202 203 232 265 281 302 335 1,183
58 63 65 72 74 78 75 81 94 99 105 116 414
85 93 103 105 117 124 129 151 172 182 197 219 769
94 90 84 83 87 94 89 87 90 98 91 97 376
36 38 39 40 49 52 47 50 53 61 58 62 234
199 290 203 205 234 250 240 257 271 303 318 348 1,239
-114 -198 -100 -101 -117 -126 -111 -106 -99 -121 -121 -129 -470
0.6 0.6 0.6 0.6 0.6 0.6 0.8 1.0 0.9 1.2 1.3 1.3 4.8
-86 -188 -115 -102 -108 -110 -95 -100 -93 -130 -112 -120 -454
0.5 -0.5 0.4 0.1 0.0 0.7 0.3 0.0 0.1 -1.7 0.4 0.2 -1.0
-86 -187 -115 -103 -108 -111 -95 -100 -93 -128 -112 -120 -453
-74 -176 -103 -91 -96 -99 -84 -89 -82 -119 -101 -109 -411

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?